Gotowa bibliografia na temat „Anti-arthritis”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Anti-arthritis”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Anti-arthritis"

1

Chaabo, Khaldoun, and Bruce Kirkham. "Rheumatoid Arthritis — Anti-TNF." International Immunopharmacology 27, no. 2 (2015): 180–84. http://dx.doi.org/10.1016/j.intimp.2015.04.051.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

KAKUMANU, PRASANTHI, ERIC S. SOBEL, SONALI NARAIN, et al. "Citrulline Dependence of Anti-Cyclic Citrullinated Peptide Antibodies in Systemic Lupus Erythematosus as a Marker of Deforming/Erosive Arthritis." Journal of Rheumatology 36, no. 12 (2009): 2682–90. http://dx.doi.org/10.3899/jrheum.090338.

Pełny tekst źródła
Streszczenie:
Objective.Anti-cyclic citrullinated peptide (CCP) antibodies are a serological marker for rheumatoid arthritis (RA); up to 10%–15% of patients with systemic lupus erythematosus (SLE) are also positive. While anti-CCP in RA is citrulline-dependent, anti-CCP in some other diseases is citrulline-independent and reacts with both CCP and the unmodified (arginine-containing) cyclic arginine peptide (CAP). We investigated the citrulline dependence of anti-CCP and its significance in the arthritis of SLE.Methods.IgG anti-CCP was compared by ELISA to anti-CAP in sera from patients with SLE (n = 335) an
Style APA, Harvard, Vancouver, ISO itp.
3

Inanc, N., E. Dalkılıc, S. Kamalı, et al. "Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis." Clinical Rheumatology 26, no. 1 (2006): 17–23. http://dx.doi.org/10.1007/s10067-006-0214-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Stewart, I., and J. C. Ridway. "Anti-Ro positive rheumatoid arthritis." Annals of the Rheumatic Diseases 45, no. 1 (1986): 86–87. http://dx.doi.org/10.1136/ard.45.1.86-b.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

HERZOG, C. "MONOCLONAL ANTI-CD4 IN ARTHRITIS." Lancet 330, no. 8573 (1987): 1461–62. http://dx.doi.org/10.1016/s0140-6736(87)91158-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Larkin, Marilynn. "Nutraceuticals' anti-arthritis benefits “exaggerated”." Lancet 355, no. 9208 (2000): 993. http://dx.doi.org/10.1016/s0140-6736(05)74734-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Mergaert, Aisha M., Mandar Bawadekar, Thai Q. Nguyen, et al. "Reduced Anti-Histone Antibodies and Increased Risk of Rheumatoid Arthritis Associated with a Single Nucleotide Polymorphism in PADI4 in North Americans." International Journal of Molecular Sciences 20, no. 12 (2019): 3093. http://dx.doi.org/10.3390/ijms20123093.

Pełny tekst źródła
Streszczenie:
Autoantibodies against citrullinated proteins are a hallmark of rheumatoid arthritis, a destructive inflammatory arthritis. Peptidylarginine deiminase 4 (PAD4) has been hypothesized to contribute to rheumatoid arthritis by citrullinating histones to induce neutrophil extracellular traps (NETs), which display citrullinated proteins that are targeted by autoantibodies to drive inflammation and arthritis. Consistent with this theory, PAD4-deficient mice have reduced NETs, autoantibodies, and arthritis. However, PAD4′s role in human rheumatoid arthritis is less clear. Here, we determine if single
Style APA, Harvard, Vancouver, ISO itp.
8

MOHAMMED, KHULOOD, JANET POPE, NICOLE LE RICHE, et al. "Association of Severe Inflammatory Polyarthritis in Primary Sjögren’s Syndrome: Clinical, Serologic, and HLA Analysis." Journal of Rheumatology 36, no. 9 (2009): 1937–42. http://dx.doi.org/10.3899/jrheum.080234.

Pełny tekst źródła
Streszczenie:
Objective.To evaluate the clinical, serologic, and MHC class II antigen characteristics of a group of patients with primary Sjögren’s syndrome (SS) and severe arthritis.Methods.A case-control study comparing 35 patients with primary SS: 17 with inflammatory arthritis, 18 without arthritis.Results.All patients fulfilled criteria for primary SS. There were no demographic or clinical features other than inflammatory arthritis, often erosive, that distinguished patients with arthritis from those without. All patients had anti-Ro/SSA autoantibodies, most had anti-La/SSB autoantibodies, and a high p
Style APA, Harvard, Vancouver, ISO itp.
9

De Vries, Charlotte, Alexandra Cîrciumaru, Linda Mathsson-Alm, et al. "Porphyromonas gingivalisassociates with the presence of anti-citrullinated protein antibodies, but not with the onset of arthritis: studies in an at-risk population." RMD Open 11, no. 1 (2025): e005111. https://doi.org/10.1136/rmdopen-2024-005111.

Pełny tekst źródła
Streszczenie:
ObjectiveThe antibody response againstPorphyromonas gingivalis(Pg) is elevated in rheumatoid arthritis (RA), especially in patients with anti-citrullinated protein antibodies (ACPA). Here, we investigated whether antibodies against thePgvirulence factor arginine gingipain (Rgp) are associated with the RA-risk phase and development of arthritis.MethodsAt-risk individuals were included in a prospective study (Risk-RA) based on a positive anti-cyclic citrullinated peptide 2 (CCP2) antibody test, and having musculoskeletal complaints but no signs of arthritis. Study participants were followed for
Style APA, Harvard, Vancouver, ISO itp.
10

Dong, Baoqi, Wenqing Wu, Jingbao Chen, and Xiao-qin Chu. "The Anti-Arthritis Effect of Cinnamaldehyde on Adjuvant Arthritis Rats." International Journal of Pharmacology 18, no. 3 (2022): 551–61. http://dx.doi.org/10.3923/ijp.2022.551.561.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Anti-arthritis"

1

Mohajane, Mamohale. "Dipeptides as potential anti-flammatory drugs for rheumatoid arthritis." Master's thesis, University of Cape Town, 2013. http://hdl.handle.net/11427/6340.

Pełny tekst źródła
Streszczenie:
Includes abstract.<br>Includes bibliographical references.<br>The H⁺ and Cu²⁺ equilibria of four glycine peptides (glycyl-glycine, glycyl-L-leucine, glycyl-L-phenylalanine and glycyl-L-histidine) and four sarcosine peptides (sarcosylglycine, sarcosyl-L-leucine, sarcosyl-L-phenylalanine and sarcosyl-L-histidine) have been studied using glass electrode potentiometry and isothermal titration calorimetry at 25 °C and an ionic strength 0.15 M (NaCl). The terminal amine of the sarcosine peptides is more basic than the glycine analogues. The methyl group on the terminal amine (for sarcosine peptides)
Style APA, Harvard, Vancouver, ISO itp.
2

Podgorski, M. R. "Clinical and pathological significance of anti-lipocortin autoantibodies in rheumatoid arthritis." Thesis, University of Southampton, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.328478.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Cleaver, Catherine Sarah. "The role of interleukin-4 and interleukin-13 in the prevention of cartilage breakdown." Thesis, University of Newcastle Upon Tyne, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.327238.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Mohamed, Ahmed A. "Redox studies on the anti-rheumatoid arthritis gold drugs : Auranofin and Solganol /." Fogler Library, University of Maine, 2000. http://www.library.umaine.edu/theses/pdf/MohamedAA2000.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Dunagan, Fiona M. "Non-steroidal anti-inflammatory drugs : pharmacokinetics and clinical response in rheumatoid arthritis." Thesis, University of Glasgow, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.236497.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Mercer, Louise. "Safety of long-term anti-TNF use, with respect to malignancy, in a national cohort of people with rheumatoid arthritis." Thesis, University of Manchester, 2013. https://www.research.manchester.ac.uk/portal/en/theses/safety-of-longterm-antitnf-use-with-respect-to-malignancy-in-a-national-cohort-of-people-with-rheumatoid-arthritis(be2ba2c3-a9a2-4a23-a3fb-c5688e990f93).html.

Pełny tekst źródła
Streszczenie:
AimThe broad aim of this thesis was to explore the risk of malignancy in people with rheumatoid arthritis (RA), treated with anti-tumour necrosis factor (TNF) drugs.MethodsThis thesis used data from patients with RA registered with the British Society of Rheumatology Biologics Register-RA. The risk of cancer in biologic-naive patients treated with traditional disease modifying drugs (nbDMARD) was compared to that in the general population by calculating standardised incidence ratios (SIR). The influence of anti-TNF on cancer risk was then explored by comparing the risk in the anti-TNF cohort t
Style APA, Harvard, Vancouver, ISO itp.
7

Mullazehi, Mohammed. "Anti-Collagen Type II Autoantibodies in an Acute Phenotype of Early Rheumatoid Arthritis." Doctoral thesis, Uppsala universitet, Institutionen för onkologi, radiologi och klinisk immunologi, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-100483.

Pełny tekst źródła
Streszczenie:
Rheumatoid arthritis (RA) is an autoimmune disease with systemic inflammatory features that primarily affects small peripheral joints. Type II collagen (CII), is the most abundant collagen type in joint cartilage. Antibodies against CII (anti-CII) are found in a subpopulation of RA patients. Anti-CII can form surface-bound immune complexes (IC) in inflamed joints, which might intensify joint inflammation and destruction. In this thesis I have studied the functional effects of surface-bound anti-CII–containing IC in vitro and correlated the results to clinical parameters. Anti-CII IC induced TN
Style APA, Harvard, Vancouver, ISO itp.
8

Phua, K. K. "The relationship between rheumatoid-factor and anti-strptococcal peptidoglycan antibody in rheumatoid arthritis." Thesis, University of Liverpool, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.370866.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

SILVA, JÚNIOR Auvani Antunes da. "Imunossensor baseado em grafeno-polissulfona para detecção da artrite reumatoide: antipeptídeo citrulinado." Universidade Federal de Pernambuco, 2016. https://repositorio.ufpe.br/handle/123456789/17776.

Pełny tekst źródła
Streszczenie:
Submitted by Fabio Sobreira Campos da Costa (fabio.sobreira@ufpe.br) on 2016-09-01T12:21:37Z No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) DISSETAÇAO_DEPOSITO.pdf: 1662534 bytes, checksum: 6bdb1ae293f1a65771c195438f64d3f0 (MD5)<br>Made available in DSpace on 2016-09-01T12:21:38Z (GMT). No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) DISSETAÇAO_DEPOSITO.pdf: 1662534 bytes, checksum: 6bdb1ae293f1a65771c195438f64d3f0 (MD5) Previous issue date: 2016-03-09<br>CAPEs<br>A artrite reumatóide (AR) é uma do
Style APA, Harvard, Vancouver, ISO itp.
10

Hui, Kwun-ho. "The diagnostic and prognostic value of anti-CCP assay in the juvenile idiopathic arthritis (JIA)." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31971817.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Anti-arthritis"

1

1940-, Orme Michael, ed. Anti-rheumatic drugs. Pergamon Press, 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Fabio, Anthony Di. The art of getting well!: Rheumatoid arthritis cured at last!! Rheumatoid Disease Foundation, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

ed, Lewis Alan 1945, Ackerman Neil ed, Otterness Ivan ed, and Inflammation Research Association. International Conference, eds. New perspectives in anti-inflammatory therapies. Raven Press, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Porter, Suzanne. Suzanne Porter's anti arthritis diet: A sensible approach for a pain-free life. Marlin Publications, 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Kandel, Joseph. The anti-arthritis diet: Increase mobility and reduce pain with this 28-day life-changing program. Primo Pub, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Research & Forecasts, Inc., ed. Arthritis and other chronic pain conditions: Problems associated with drug therapy. Research & Forecasts, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

G, Lombardino J., ed. Nonsteroidal antiinflammatory drugs. Wiley, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

European Congress of Rheumatology (11th 1987 Athens, Greece). Tenoxicam: Presentations to the XIth European Congress of Rheumatology, 1987. Edited by Cairns A. EULAR, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

B, Sudderth David, ed. The anti-arthritis diet: Increase mobility and reduce pain with this 28-day life-changing program. Prima Health, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

F, Willkens Robert, and Dahl Stephen L, eds. Therapeutic controversies in the rheumatic diseases. Grune & Stratton, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Anti-arthritis"

1

Saha, Kunal Kumar, Anik Barman, and Narayan Chandra Mandal. "Anti-Inflammatory and Anti-Arthritis Properties of Ganoderma." In Ganoderma. CRC Press, 2024. http://dx.doi.org/10.1201/9781003354789-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Hassfeld, W., G. Steiner, W. Graninger, and J. S. Smolen. "Anti-RA33: A New Antinuclear Antibody in Rheumatoid Arthritis." In Rheumatoid Arthritis. Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-76189-8_21.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Wang, Peng, Xuegang Luo, Chongxi Wang, Xinjia Wang, Guang Hu, and Tong-Cun Zhang. "Research Progress on the Anti-Rheumatoid Arthritis Drugs." In Proceedings of the 2012 International Conference on Applied Biotechnology (ICAB 2012). Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-37922-2_94.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Ebringer, Alan. "Anti-Proteus Antibodies in Norwegian Rheumatoid Arthritis Patients Following a Lactovegetarian Diet." In Rheumatoid Arthritis and Proteus. Springer London, 2011. http://dx.doi.org/10.1007/978-0-85729-950-5_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Bosch, X., J. Llena, J. Font, et al. "Anti-Granulocyte Perinuclear Antibodies but Not Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Rheumatoid Arthritis." In Advances in Experimental Medicine and Biology. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9182-2_64.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Emmrich, F., G. Horneff, W. Becker, et al. "An Anti-CD4 Antibody for Treatment of Chronic Inflammatory Arthritis." In Drugs in Inflammation. Birkhäuser Basel, 1991. http://dx.doi.org/10.1007/978-3-0348-7405-2_22.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Goldblatt, F., and D. A. Isenberg. "Anti-CD20Monoclonal Antibody in Rheumatoid Arthritis and Systemic Lupus Erythematosus." In Therapeutic Antibodies. Springer Berlin Heidelberg, 2008. http://dx.doi.org/10.1007/978-3-540-73259-4_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Coremans, Ida E. M., Ernst C. Hagen, Fokko J. van der Woude, et al. "Anti-Lactoferrin Antibodies in Patients with Rheumatoid Arthritis with Vasculitis." In Advances in Experimental Medicine and Biology. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9182-2_60.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Sundy, John S. "Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Rheumatoid Arthritis." In Modern Therapeutics in Rheumatic Diseases. Humana Press, 2002. https://doi.org/10.1007/978-1-59259-239-5_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Taylor, P. C., R. O. Williams, and R. N. Maini. "Anti-TNFα Therapy in Rheumatoid Arthritis - Current and Future Directions." In Current Directions in Autoimmunity. KARGER, 2000. http://dx.doi.org/10.1159/000060499.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Anti-arthritis"

1

Li, Yan, Zibo Ouyang, Rui Li, and Shao Li. "Network analysis for anti-rheumatoid arthritis TCM prescriptions." In 2013 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2013. http://dx.doi.org/10.1109/bibm.2013.6732651.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Zhan, Junping, and Guang Zheng. "Anti-rheumatoid Arthritis Mechanisms of Angelicae Pubescentis Radix." In 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2019. http://dx.doi.org/10.1109/bibm47256.2019.8982935.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Parchami, Ghazaee, Kateryna Marchenko-Tolsta, Novykova Larisa, and Mykola Hryshkov. "ANTI-INFLAMMATORY PROPERTIES OF PHYTOCONSTITUENTS IN MANAGING RHEUMATOID ARTHRITIS." In RICERCHE SCIENTIFICHE E METODI DELLA LORO REALIZZAZIONE: ESPERIENZA MONDIALE E REALTÀ DOMESTICHE. European Scientific Platform, 2024. http://dx.doi.org/10.36074/logos-26.04.2024.090.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Kolarz, Bogdan, Magdalena Dryglewska, Marek Ciesla, and Maria Majdan. "THU0139 IS ADDING ANTI-CARP OR ANTI-PADI4 BENEFICIAL FOR DIAGNOSIS OF RHEUMATOID ARTHRITIS?" In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.2117.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Regueiro, C., A. Montes, MD Boveda, et al. "FRI0040 Characterization of anti-carbamylated synovial protein antibodies (ANTI-CARPS) in rheumatoid arthritis patients." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.4789.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Nenasheva, NV, AS Trofimenko, IP Gontar, LA Maslakova, OA Rusanova, and OV Paramonova. "FRI0146 Anti-elastin and anti-elastase autoantibodies: potential clinical and diagnostic implications in rheumatoid arthritis." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.2593.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Carbone, Teresa, Carmela Esposito, Ornella Mercuro, et al. "SAT0645 ANTI-DFS70 AUTOANTIBODIES INDUCED BY ANTI-TNF THERAPY IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS PATIENTS." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.5636.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Volkava, M., and A. Kundzer. "SAT0660 Clinical significance of anti-ra33 autoantybodies in rheumatoid arthritis." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.6873.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Ratanawatkul, P., J. J. Swigris, and J. J. Solomon. "Positive Anti-Cyclic Citrullinated Peptide (anti-CCP) May Not Be a Pre-Phenotype for Rheumatoid Arthritis." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1794.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Verhoeven, F., C. Prati, P. Totoson, R. Bordy, D. Wendling та C. Demougeot. "FRI0044 Non-steroidal anti-inflammatory drugs are more beneficial than anti-tnfα drugs on the radiographic damage in arthritis: a study in adjuvant induced arthritis". У Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.2611.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Anti-arthritis"

1

Koleva, Kalina, Stanislav Marchev, Rumen Nikolov, Mila Vlaskovska, and Slavina Surcheva. The Role of Diabetes on Experimental Arthritis: Analgesic, Anti-inflammatory and Adverse Effects of NSAID. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2020. http://dx.doi.org/10.7546/crabs.2020.09.14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Mamus, M. A., E. A. Tikhomirova, S. A. Bedina, S. S. Dotsenko, A. S. Trofimenko, and E. E. Mozgovaya. NEUTROPHIL EXTRACELLULAR TRAPS AND THEIR EVENTUAL ROLE IN THE ANTI-CITRULLINATED PROTEIN ANTIBODIES GENERATION IN RHEUMATOID ARTHRITIS. Планета, 2018. http://dx.doi.org/10.18411/978-5-907109-24-7-2018-xxxv-202-211.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Aleksandrov, A. V., N. V. Nikitinа, N. V. Aleksandrova, I. А. Zborovskaya, and Y. A. Trubenko. PECULIARITIES OF DIAGNOSTICS OF DIASTOLIC FORM OF CARDIAC INSUFFICIENCY IN PATIENTS WITH ANTI-CCP POSITIVE RHEUMATOID ARTHRITIS. "PLANET", 2019. http://dx.doi.org/10.18411/978-5-907192-54-6-2019-xxxvi-12-18.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Fan, Yihua, Xiaoyin Zhao, Xiaoxu He, and Huixin Chen. Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A protocol of a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.4.0153.

Pełny tekst źródła
Streszczenie:
Review question / Objective: To evaluate the efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis. Eligibility criteria: 1.1.1 Literature type Randomized controlled trials of treating AGA with Chinese herbal compound alone, whether blind or not, was limited to Chinese literature and English literature.1.1.2 SubjectsThe time of onset, gender, and age of patients diagnosed with acute gouty arthritis were not restricted.1.1.3 Intervention measures The treatment group was treated with traditional Chinese medicine compound, which could be proprietary Chinese medi
Style APA, Harvard, Vancouver, ISO itp.
5

Fan, Yihua, Xiaoyin Zhao, Xiaoxu He, and Huixin Chen. Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A protocol of a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.4.0153.

Pełny tekst źródła
Streszczenie:
Review question / Objective: To evaluate the efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis. Eligibility criteria: 1.1.1 Literature type Randomized controlled trials of treating AGA with Chinese herbal compound alone, whether blind or not, was limited to Chinese literature and English literature.1.1.2 SubjectsThe time of onset, gender, and age of patients diagnosed with acute gouty arthritis were not restricted.1.1.3 Intervention measures The treatment group was treated with traditional Chinese medicine compound, which could be proprietary Chinese medi
Style APA, Harvard, Vancouver, ISO itp.
6

Yang, Xiaochun, Yue Cai, Bin Xue, and Bo Zhang. Diagnostic value of anti-cyclic citrullinated peptide antibody combined with rheumatoid factor in rheumatoid arthritis in Asia: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.8.0106.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Xie, Sisi, Shu Li, Bilin Chen, Qing Zhu, Lichang Xu, and Fen Li. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-associated interstitial lung disease: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.4.0071.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!